Equity

Key Financial Ratios Home > Equity > Corporate Information > Key Financial Ratios

Biocon LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532523 NSE Symbol: BIOCON P/E (TTM) :0
ISIN Demat:INE376G01013 Div & Yield %:0.5 EPS (TTM) :0.4
Book Value (RS) :90.3831418 Market Cap (Rs Cr.):35849.92 Face Value (RS) :5
    Change Company 
YearsMar 2023Mar 2022Mar 2021Mar 2020Mar 2019
Debt-Equity Ratio0.070.010.000.010.01
Long Term Debt-Equity Ratio0.070.000.000.010.01
Current Ratio3.403.523.052.752.45
Fixed Assets0.840.800.990.870.74
Inventory3.623.584.202.982.62
Debtors2.932.663.442.702.18
Interest Cover Ratio2.22350.25898.00325.08124.58
PBIDTM (%)13.6014.2822.8124.5523.31
PBITM (%)7.748.0617.7119.6218.14
PBDTM (%)10.1114.2622.7924.4923.16
CPM (%)5.2011.1818.9320.2523.43
APATM (%)-0.674.9513.8315.3218.26
ROCE (%)1.501.724.605.244.54
RONW (%)-0.141.083.634.164.71

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)